MOOLEC SCIENCE SA (MLEC)
LU2559000059 - Common Stock
Taking everything into account, MLEC scores 1 out of 10 in our fundamental rating. MLEC was compared to 90 industry peers in the Food Products industry. MLEC may be in some trouble as it scores bad on both profitability and health. MLEC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year MLEC has reported negative net income.
MLEC had a negative operating cash flow in the past year.
In the past 5 years MLEC always reported negative net income.
MLEC had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -237.33%, MLEC is not doing good in the industry: 97.78% of the companies in the same industry are doing better.
MLEC's Return On Equity of -600.34% is on the low side compared to the rest of the industry. MLEC is outperformed by 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -237.33% | ||
| ROE | -600.34% | ||
| ROIC | N/A |
ROA(3y)-73.27%
ROA(5y)N/A
ROE(3y)-207.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for MLEC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
MLEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
MLEC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -3.95, we must say that MLEC is in the distress zone and has some risk of bankruptcy.
MLEC has a worse Altman-Z score (-3.95) than 85.56% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that MLEC is not too dependend on debt financing.
MLEC's Debt to Equity ratio of 0.03 is amongst the best of the industry. MLEC outperforms 82.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.95 |
ROIC/WACCN/A
WACC7.22%
2.3 Liquidity
MLEC has a Current Ratio of 0.26. This is a bad value and indicates that MLEC is not financially healthy enough and could expect problems in meeting its short term obligations.
MLEC's Current ratio of 0.26 is on the low side compared to the rest of the industry. MLEC is outperformed by 96.67% of its industry peers.
MLEC has a Quick Ratio of 0.26. This is a bad value and indicates that MLEC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.22, MLEC is not doing good in the industry: 94.44% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%68.29%
3.2 Future
MLEC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.84% yearly.
Based on estimates for the next years, MLEC will show a very strong growth in Revenue. The Revenue will grow by 106.59% on average per year.
EPS Next Y-32.6%
EPS Next 2Y-10.63%
EPS Next 3Y30.14%
EPS Next 5Y33.84%
Revenue Next Year15.44%
Revenue Next 2Y22.5%
Revenue Next 3Y137.77%
Revenue Next 5Y106.59%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MLEC. In the last year negative earnings were reported.
Also next year MLEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MLEC's earnings are expected to grow with 30.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.63%
EPS Next 3Y30.14%
5. Dividend
5.1 Amount
MLEC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MOOLEC SCIENCE SA
NASDAQ:MLEC (12/30/2024, 12:45:15 PM)
0.771
-0.04 (-5.05%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners3.53%
Ins Owner ChangeN/A
Market Cap29.66M
Analysts82.86
Price Target3.06 (296.89%)
Short Float %2.29%
Short Ratio6.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.61%
Min EPS beat(2)1.96%
Max EPS beat(2)73.26%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)115.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 11.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.34 | ||
| P/tB | 94.87 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.07
BVpS0.23
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -237.33% | ||
| ROE | -600.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-73.27%
ROA(5y)N/A
ROE(3y)-207.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | -3.95 |
F-Score4
WACC7.22%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-32.6%
EPS Next 2Y-10.63%
EPS Next 3Y30.14%
EPS Next 5Y33.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%68.29%
Revenue Next Year15.44%
Revenue Next 2Y22.5%
Revenue Next 3Y137.77%
Revenue Next 5Y106.59%
EBIT growth 1Y-189.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.33%
EBIT Next 3Y25.49%
EBIT Next 5Y21.71%
FCF growth 1Y-506.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-498.71%
OCF growth 3YN/A
OCF growth 5YN/A